SUMO4 163 G>A variation is associated with kidney disease in Indian subjects with type 2 diabetes
- 7 April 2016
- journal article
- research article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 43 (5) , 345-348
Abstract
Genetic susceptibility probably plays a role in the development and/or progression of diabetic kidney disease. Small ubiquitin-related modifier 4 (SUMO4) mRNA is expressed in human kidney. Substitution of methionine with valine at codon 55 (M55V) of SUMO4 gene induces higher nuclear factor-kB activity, which is known to mediate the development of kidney disease in individuals with diabetes. We investigated the association between the SUMO4 M55V (rs237025, c.163 G>A) and kidney disease in north Indian subjects with diabetes. A case–control analysis was performed using genomic DNA samples from 216 diabetic patients without nephropathy (DM) and 201 diabetic with nephropathy (DN). The SUMO4 c.163 G>A polymorphism was genotyped using polymerase chain reaction amplification followed by restriction digestion. The duration of diabetes was significantly greater in DN. The genotypic and allelic frequencies were different in DM and DN groups: GG genotype was significantly more frequent in DN as compared to DM (p = 0.018, OR 1.72, 95 % CI 1.1–2.7). Similarly the G allele was more frequent in DN compared to DM (p = 0.017, OR 1.4, 95 % CI 1.1–1.8). This study suggests that SUMO4 c.163 G>A polymorphism is associated with the susceptibility to diabetic nephropathy in north Indian subjects with type 2 diabetes.Keywords
Funding Information
- Anusandhan National Research Foundation (SR/SO/HS/008/2009)
This publication has 22 references indexed in Scilit:
- Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complicationsThe Review of Diabetic Studies, 2012
- L-carnosine inhibits high-glucose-mediated matrix accumulation in human mesangial cells by interfering with TGF- production and signallingNephrology Dialysis Transplantation, 2011
- The activation of NF-κB and AP-1 in peripheral blood mononuclear cells isolated from patients with diabetic nephropathyDiabetes Research and Clinical Practice, 2008
- Genetic Factors in Diabetic NephropathyClinical Journal of the American Society of Nephrology, 2007
- A M55V Polymorphism in the SUMO4 Gene is Associated with a Reduced Prevalence of Diabetic Retinopathy in Patients with Type 1 DiabetesExperimental and Clinical Endocrinology & Diabetes, 2007
- SUMO4 M55V Variant Is Associated With Diabetic Nephropathy in Type 2 DiabetesDiabetes, 2007
- Chemotactic cytokine receptor 5 (CCR5) gene promoter polymorphism (59029A/G) is associated with diabetic nephropathy in Japanese patients with type 2 diabetes: A 10-year longitudinal studyDiabetes Research and Clinical Practice, 2006
- NF- B activation and overexpression of regulated genes in human diabetic nephropathyNephrology Dialysis Transplantation, 2004
- Insufficient Glycemic Control Increases Nuclear Factor-κB Binding Activity in Peripheral Blood Mononuclear Cells Isolated From Patients With Type 1 DiabetesDiabetes Care, 1998
- Familial factors determine the development of diabetic nephropathy in patients with IDDMDiabetologia, 1996